HoyleCohen’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$209K Buy
+4,000
New +$175K 0.02% 261
2024
Q1
Sell
-8,775
Closed -$324K 283
2023
Q4
$324K Buy
8,775
+675
+8% +$25.4K 0.03% 222
2023
Q3
$309K Hold
8,100
0.03% 211
2023
Q2
$292K Hold
8,100
0.03% 226
2023
Q1
$309K Hold
8,100
0.03% 218
2022
Q4
$461K Buy
8,100
+700
+9% +$35.8K 0.05% 188
2022
Q3
$293K Hold
7,400
0.03% 211
2022
Q2
$326K Hold
7,400
0.03% 205
2022
Q1
$295K Hold
7,400
0.03% 225
2021
Q4
$298K Hold
7,400
0.02% 233
2021
Q3
$301K Hold
7,400
0.03% 218
2021
Q2
$336 Hold
7,400
0.03% 214
2021
Q1
$309K Hold
7,400
0.03% 214
2020
Q4
$316K Buy
+7,400
New +$266K 0.04% 187

Other funds holding HALO

HoyleCohen's HALO Position: Q2 2024 in Review

HoyleCohen opened a new position in Halozyme (HALO) in Q2 2024: 4,000 shares worth $209K. The stake represents 0.02% of the portfolio and ranks #261 among its holdings. This is a return to the name: HoyleCohen previously reported a position in HALO as recently as Q4 2023.

HoyleCohen first reported a position in HALO in Q4 2020 and has held it in 14 quarters since. The position peaked at $461K in Q4 2022. 460 funds tracked by Wall St. Rank hold HALO as of Q2 2024.

  • HoyleCohen held 4,000 shares of Halozyme worth $209K as of Q2 2024.
  • Halozyme was a new HoyleCohen position in Q2 2024.
  • Halozyme made up 0.02% of HoyleCohen's portfolio in Q2 2024, its #261 holding.
  • HoyleCohen first reported a position in Halozyme in Q4 2020 and has held it in 14 quarters since.
  • HoyleCohen's Halozyme position peaked at $461K in Q4 2022.
  • 460 funds tracked by Wall St. Rank held Halozyme as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.